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Background/introduction
MRgFUS offers unambiguous advantages over other cur-
rent treatment modalities, as it is noninvasive and does
not use ionizing radiation. Further, ultrasonically-
controlled stable and inertial microbubble oscillations
exert forces that can, among others, activate cell’s
mechanoreceptors, disrupt cellular and vascular mem-
branes, accelerate the dissolution of blood clots, enhance
thermal ablation, and induce localized tissue erosionetc.
FUS can also be used transcranially for tumor ablation,
blood-brain barrier disruption, neuromodulation, etc.
Harnessing and, potentially, combining these abilities
holds great promise for therapy and diagnosis of cancer
and cardiovascular and central nervous system diseases
and disorders. For the wide-spread use of these
approaches, development of methods and technology to
enable precise planning, monitoring and control, and
assessment of their outcome are essential.
Methods
We developed a novel noninvasive and clinically relevant
framework (Fig. 1) that combines i) multimodality ima-
ging (US/MR/CT), ii) 3D Finite Difference Time Domain
(FDTD) numerical simulations, and iii) an integrated MR
and US imaging FUS system for guiding FUS therapy.
The proposed framework enables accurate treatment
planning, via visualization of anatomic structures (MRI),
extraction of their acoustic properties (CT) and simula-
tion of US propagation (3D FDTD), which includes rea-
listic microbubble acoustic emissions. The co-registration
of CT (skull) with the MR and US datasets allowed us to
model and study the microbubble emissions propagation
through the skull and refine a standard PAM back-pro-
jection algorithm to account for spatially varying wave
propagation effects, such as refraction and diffraction.
The key component of our framework is the MR and US
imaging guided FUS system that is used to monitor and
control both the thermal and mechanical effects of FUS
transcranially, here using manual and simple on-off
controllers.
Finally, using MR contrast agent as drug surrogate, the
proposed framework is used to assess drug uptake after
FUS-BBB disruption.
Results and conclusions
The incorporation of a variable speed of sound to the
PAM back-projection algorithm corrected the aberra-
tions introduced by the skull (NHP and Human). Further,
more than 94% agreement in the FWHM of the axial and
transverse line profiles between the simulations incorpor-
ating microbubble emissions and experimentally-deter-
mined PAMs was observed in NHP. The acoustic
emissions monitoring allowed to fine-tune the sonication
power for efficacious FUS-BBB disruption in glioma-
bearing rat, while, MR temperature imaging based FUS
controller allowed to attain constant focal temperature
(temperature rise: 7±1.5 0C, for 5 mins) in the brain of a
healthy rat. These abilities that have not been previously
shown provide a clinically relevant framework for guiding
FUS in the brain. We envision that the proposed frame-
work will be essential for developing, optimizing, and
translating current and new therapeutic FUS approaches
to the clinics.
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Figure 1 Image Guided FUS framework
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